Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PKCδ mediates high-fat diet-induced increased tonic GABA <sub>A</sub> receptor current in cardiac vagal motor neurons in the DMV.

bioRxiv : the preprint server for biology·2026

Same author

Author Correction: Rewiring oncogenic signalling to precision ablation of metastatic cancer.

Nature biomedical engineering·2026

Same author

Esr1-dependent signaling and transcriptional maturation in the medial preoptic area of the hypothalamus shape the development of mating behavior during adolescence.

eLife·2026

Same author

Rewiring oncogenic signalling to precision ablation of metastatic cancer.

Nature biomedical engineering·2026

Same author

Microenvironment T-Type calcium channels regulate neuronal and glial processes in tumor cells to promote glioblastoma growth.

Neuro-oncology·2026

Same author

Drug-induced changes in connectivity to midbrain dopamine cells revealed by rabies monosynaptic tracing.

eLife·2026

Search research articles

Related Experiment Video

Updated: May 7, 2025

Control of Eating Behavior Using a Novel Feedback System

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

A Brain Reward Circuit Inhibited By Next-Generation Weight Loss Drugs.

Elizabeth N Godschall, Taha Bugra Gungul, Isabelle R Sajonia

Biorxiv : the Preprint Server for Biology

|January 7, 2025

Summary

New small-molecule glucagon-like peptide-1 receptor agonists (GLP1RAs) target brain circuits to control appetite. These drugs modulate both metabolic and reward-driven feeding behaviors, offering potential for obesity and addiction treatments.

More Related Videos

Studying Food Reward and Motivation in Humans

Studying Food Reward and Motivation in Humans

Published on: March 19, 2014

Fat Preference: A Novel Model of Eating Behavior in Rats

Fat Preference: A Novel Model of Eating Behavior in Rats

Published on: June 27, 2014

Related Experiment Videos

Last Updated: May 7, 2025

Control of Eating Behavior Using a Novel Feedback System

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Studying Food Reward and Motivation in Humans

Studying Food Reward and Motivation in Humans

Published on: March 19, 2014

Fat Preference: A Novel Model of Eating Behavior in Rats

Fat Preference: A Novel Model of Eating Behavior in Rats

Published on: June 27, 2014

Area of Science:

Neuroscience
Pharmacology
Metabolic Diseases

Background:

Glucagon-like peptide-1 receptor agonists (GLP1RAs) are effective for weight loss but typically require injections.
Small-molecule GLP1RAs offer oral bioavailability and scalable manufacturing but lack detailed mechanistic understanding.
Neural circuits underlying small-molecule GLP1RA effects on feeding are largely undefined.

Purpose of the Study:

To investigate the neural mechanisms by which small-molecule GLP1RAs modulate feeding behavior.
To compare the neural circuit engagement of small-molecule GLP1RAs with peptide-based GLP1RAs.
To identify specific brain regions and pathways targeted by small-molecule GLP1RAs.

Main Methods:

Development of humanized GLP1R mouse models.
Integration of genetic manipulations, calcium imaging, and behavioral profiling.
Analysis of neural activity and dopamine release in response to small-molecule GLP1RAs.

Main Results:

Small-molecule GLP1RAs regulate both homeostatic and hedonic feeding through distinct neural circuits.
GLP1RAs activate central amygdala neurons, suppressing palatable food intake via dopamine modulation in the nucleus accumbens.
Targeting GLP1 receptors in the central amygdala specifically affects reward-driven feeding.

Conclusions:

Small-molecule GLP1RAs engage a dedicated neural circuit in the central amygdala to modulate reward processing and hedonic feeding.
These findings reveal a novel mechanism for small-molecule GLP1RAs, distinct from canonical pathways.
Small-molecule GLP1RAs show therapeutic potential for conditions involving dysregulated dopamine signaling, such as substance use disorder and binge eating.